These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 16115624)

  • 1. Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias.
    Janovick JA; Spicer TP; Bannister TD; Scampavia L; Conn PM
    PLoS One; 2017; 12(8):e0181830. PubMed ID: 28767678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target immobilization on glass microfiber membranes as a label-free strategy for hit identification.
    Wang Y; He Y; Ye X; Zhang Y; Huang X; Liu H; Dong W; Yang D; Guo D
    Anal Bioanal Chem; 2023 Nov; 415(27):6743-6755. PubMed ID: 37730920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of a loss-of-function mutant I324M of arginine vasopressin receptor 2 in X-linked nephrogenic diabetes insipidus.
    Wang L; Guo W; Fang C; Feng W; Huang Y; Zhang X; Liu M; Cui J
    Sci Rep; 2021 May; 11(1):11057. PubMed ID: 34040143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation analysis of G protein-coupled receptor by mass spectrometry: identification of a phosphorylation site in V2 vasopressin receptor.
    Wu S; Birnbaumer M; Guan Z
    Anal Chem; 2008 Aug; 80(15):6034-7. PubMed ID: 18578504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A serine cluster prevents recycling of the V2 vasopressin receptor.
    Innamorati G; Sadeghi HM; Tran NT; Birnbaumer M
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2222-6. PubMed ID: 9482866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.
    Birnbaumer M; Gilbert S; Rosenthal W
    Mol Endocrinol; 1994 Jul; 8(7):886-94. PubMed ID: 7984150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calmodulin interacts with the V2 vasopressin receptor: elimination of binding to the C terminus also eliminates arginine vasopressin-stimulated elevation of intracellular calcium.
    Nickols HH; Shah VN; Chazin WJ; Limbird LE
    J Biol Chem; 2004 Nov; 279(45):46969-80. PubMed ID: 15319442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An X-linked NDI mutation reveals a requirement for cell surface V2R expression.
    Sadeghi HM; Innamorati G; Birnbaumer M
    Mol Endocrinol; 1997 Jun; 11(6):706-13. PubMed ID: 9171234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hydrophobic amino acid residues in the membrane-proximal C tail of the G protein-coupled vasopressin V2 receptor are necessary for transport-competent receptor folding.
    Thielen A; Oueslati M; Hermosilla R; Krause G; Oksche A; Rosenthal W; Schülein R
    FEBS Lett; 2005 Sep; 579(23):5227-35. PubMed ID: 16162341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for K268 in V2R folding.
    Gouill CL; Darden T; Madziva MT; Birnbaumer M
    FEBS Lett; 2005 Sep; 579(22):4985-90. PubMed ID: 16115624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.
    Juul KV; Bichet DG; Nielsen S; Nørgaard JP
    Am J Physiol Renal Physiol; 2014 May; 306(9):F931-40. PubMed ID: 24598801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
    Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
    Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.